
|Articles|August 1, 2007
Value-based formularies aim to increase access
A value-based formulary takes into account individual illnesses and varies financial incentives determined by how important a medication is to a patient.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
Medicaid tech companies pledge $600 million to help states update systems
4
Why the great pharma-MedTech divide is healthcare’s biggest miss
5























